Variant report
Variant | rs2602482 |
---|---|
Chromosome Location | chr11:77013928-77013929 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:30)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:30 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | TEAD4 | chr11:77013757-77014165 | K562 | blood: | n/a | n/a |
2 | TBL1XR1 | chr11:77013861-77014112 | K562 | blood: | n/a | n/a |
3 | TEAD4 | chr11:77013707-77014247 | K562 | blood: | n/a | n/a |
4 | GATA1 | chr11:77013672-77014336 | K562 | blood: | n/a | n/a |
5 | EP300 | chr11:77013667-77014496 | SK-N-SH | brain: | n/a | n/a |
6 | ARID3A | chr11:77013780-77014029 | HepG2 | liver: | n/a | n/a |
7 | HDAC2 | chr11:77013847-77014085 | K562 | blood: | n/a | n/a |
8 | RCOR1 | chr11:77013760-77014234 | K562 | blood: | n/a | n/a |
9 | GABPA | chr11:77013875-77014113 | K562 | blood: | n/a | n/a |
10 | MYC | chr11:77013830-77014120 | K562 | blood: | n/a | n/a |
11 | HNF4A | chr11:77013801-77014002 | HepG2 | liver: | n/a | n/a |
12 | UBTF | chr11:77013912-77013943 | K562 | blood: | n/a | n/a |
13 | JUND | chr11:77013824-77014180 | K562 | blood: | n/a | n/a |
14 | FOXA1 | chr11:77013727-77014058 | HepG2 | liver: | n/a | chr11:77013888-77013900 |
15 | RCOR1 | chr11:77013811-77014191 | K562 | blood: | n/a | n/a |
16 | GATA2 | chr11:77013857-77014097 | K562 | blood: | n/a | n/a |
17 | FOXA2 | chr11:77013781-77013994 | HepG2 | liver: | n/a | chr11:77013888-77013900 |
18 | CCNT2 | chr11:77013898-77014156 | K562 | blood: | n/a | n/a |
19 | ZMIZ1 | chr11:77013853-77014177 | K562 | blood: | n/a | n/a |
20 | EP300 | chr11:77013806-77014233 | K562 | blood: | n/a | n/a |
21 | NR2F2 | chr11:77013799-77014134 | K562 | blood: | n/a | n/a |
22 | POLR2A | chr11:77013834-77014071 | K562 | blood: | n/a | n/a |
23 | MAFK | chr11:77013717-77014265 | HepG2 | liver: | n/a | n/a |
24 | TRIM28 | chr11:77013782-77014178 | K562 | blood: | n/a | n/a |
25 | ARID3A | chr11:77013878-77014159 | K562 | blood: | n/a | n/a |
26 | PML | chr11:77013827-77014154 | K562 | blood: | n/a | n/a |
27 | GATA2 | chr11:77013812-77014308 | SH-SY5Y | brain: | n/a | n/a |
28 | TAL1 | chr11:77013797-77014210 | K562 | blood: | n/a | n/a |
29 | HNF4A | chr11:77013749-77014017 | HepG2 | liver: | n/a | n/a |
30 | GATA3 | chr11:77013889-77014041 | SH-SY5Y | brain: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GDPD4 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10899366 | 0.95[CHB][hapmap];0.82[JPT][hapmap] |
rs10899367 | 0.94[CHB][hapmap];0.81[JPT][hapmap] |
rs11237200 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs11820118 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs11823572 | 0.81[ASN][1000 genomes] |
rs11828786 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs12420360 | 0.95[CHB][hapmap];1.00[JPT][hapmap] |
rs2100393 | 0.87[ASN][1000 genomes] |
rs2154754 | 0.89[JPT][hapmap] |
rs2156863 | 0.95[CHB][hapmap];0.82[JPT][hapmap] |
rs2602471 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2602473 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2602474 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2602475 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2602480 | 0.95[CHB][hapmap];0.82[JPT][hapmap] |
rs2602481 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs2602484 | 0.92[ASN][1000 genomes] |
rs2725829 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2729756 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs2729758 | 0.95[CHB][hapmap];0.82[JPT][hapmap] |
rs2729763 | 0.85[ASN][1000 genomes] |
rs2729772 | 1.00[CHB][hapmap];0.82[JPT][hapmap];0.83[ASN][1000 genomes] |
rs2729775 | 0.88[CHB][hapmap];0.92[JPT][hapmap] |
rs2844327 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs2852388 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2852390 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2853085 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs2853094 | 1.00[CEU][hapmap];0.94[CHB][hapmap];0.82[JPT][hapmap] |
rs2853095 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs2853098 | 0.95[CHB][hapmap];0.89[JPT][hapmap] |
rs2888377 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs34375485 | 0.84[ASN][1000 genomes] |
rs733358 | 0.89[CHB][hapmap];0.89[JPT][hapmap];0.87[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs745458 | 0.87[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs876319 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs896841 | 0.81[ASN][1000 genomes] |
rs947810 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs9634030 | 0.95[CHB][hapmap];0.82[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv534515 | chr11:76900813-77035769 | Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Active TSS Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
2 | nsv1048360 | chr11:76900813-77387933 | Strong transcription Flanking Active TSS Enhancers Weak transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
3 | nsv541089 | chr11:76900813-77387933 | Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
4 | nsv1049603 | chr11:76900813-77520411 | Strong transcription Weak transcription Active TSS Enhancers Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
5 | nsv541090 | chr11:76900813-77520411 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
6 | esv3424135 | chr11:76961603-77277087 | Strong transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:77013600-77014600 | Enhancers | HepG2 | liver |
2 | chr11:77013800-77014000 | Enhancers | Liver | Liver |
3 | chr11:77013800-77015200 | Enhancers | HUES64 Cell Line | embryonic stem cell |